These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33344254)

  • 1. Metabolism-Associated Molecular Classification of Colorectal Cancer.
    Zhang M; Wang HZ; Peng RY; Xu F; Wang F; Zhao Q
    Front Oncol; 2020; 10():602498. PubMed ID: 33344254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism-associated molecular classification of hepatocellular carcinoma.
    Yang C; Huang X; Liu Z; Qin W; Wang C
    Mol Oncol; 2020 Apr; 14(4):896-913. PubMed ID: 31955511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning revealed molecular classification of colorectal cancer with negative lymph node metastasis.
    Liu L; Liu J; Wang J; Yuan W
    Biomarkers; 2022 Feb; 27(1):86-94. PubMed ID: 34894932
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic Heterogeneity of Tumor Cells and its Impact on Colon Cancer Metastasis: Insights from Single-Cell and Bulk Transcriptome Analyses.
    Jia Y; Feng G; Chen S; Li W; Jia Z; Wang J; Li H; Hong S; Dai F
    J Cancer; 2024; 15(13):4175-4196. PubMed ID: 38947396
    [No Abstract]   [Full Text] [Related]  

  • 5. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
    Liu Z; Xu H; Weng S; Ren Y; Han X
    Front Immunol; 2022; 13():828330. PubMed ID: 35154148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy.
    Yang R; Wang Z; Li J; Pi X; Gao R; Ma J; Qing Y; Zhou S
    Front Cell Dev Biol; 2021; 9():707677. PubMed ID: 34458265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-and Metabolism-Associated Molecular Classification of Ovarian Cancer.
    Chen Z; Jiang W; Li Z; Zong Y; Deng G
    Front Oncol; 2022; 12():877369. PubMed ID: 35646692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies.
    Liu Z; Guo Y; Yang X; Chen C; Fan D; Wu X; Si C; Xu Y; Shao B; Chen Z; Dang Q; Cui W; Han X; Ji Z; Sun Z
    Front Cell Dev Biol; 2021; 9():784199. PubMed ID: 35083217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
    Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
    Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism-associated molecular classification of gastric adenocarcinoma.
    Ye Y; Yang W; Ruan X; Xu L; Cheng W; Zhao M; Wang X; Chen X; Cai D; Li G; Wang Y; Yan F; Lu X; Jiang L
    Front Oncol; 2022; 12():1024985. PubMed ID: 36465405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of immune-related signatures of colorectal cancer identifying two different immune phenotypes: Evidence for immune checkpoint inhibitor therapy.
    Chen G; Wang L; Diao T; Chen Y; Cao C; Zhang X
    Oncol Lett; 2020 Jul; 20(1):517-524. PubMed ID: 32565977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
    Jézéquel P; Loussouarn D; Guérin-Charbonnel C; Campion L; Vanier A; Gouraud W; Lasla H; Guette C; Valo I; Verrièle V; Campone M
    Breast Cancer Res; 2015 Mar; 17():43. PubMed ID: 25887482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
    Zhao L; Zhao H; Yan H
    BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of metabolism-associated gene signatures in colorectal cancer.
    Miao Y; Li Q; Wang J; Quan W; Li C; Yang Y; Mi D
    PeerJ; 2020; 8():e9847. PubMed ID: 32953273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular characteristics of bladder urothelial carcinoma subtypes.
    Li Y; Yang K; Li K; Liu H; Zhao S; Jiao M; Fu X
    J Cell Biochem; 2019 Jun; 120(6):9956-9963. PubMed ID: 30548659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis.
    Miyake M; Takemasa I; Matoba R; Tanino M; Niijima S; Ikeda M; Yamamoto H; Sekimoto M; Kuhara S; Okayama T; Monden M; Matsubara K; Mori M
    Int J Oncol; 2011 Oct; 39(4):781-9. PubMed ID: 21701771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
    Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
    Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma.
    Zhang J; Zhang Q; Shi Y; Wang P; Gong Y; He S; Li Z; Feng N; Wang Y; Jiang P; Ci W; Li X; Zhou L
    Front Mol Biosci; 2022; 9():837145. PubMed ID: 35419412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.